» Articles » PMID: 31196980

Endothelial ERK1/2 Signaling Maintains Integrity of the Quiescent Endothelium

Overview
Journal J Exp Med
Date 2019 Jun 15
PMID 31196980
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

To define the role of ERK1/2 signaling in the quiescent endothelium, we induced endothelial knockout in adult mice. This resulted in a rapid onset of hypertension, a decrease in eNOS expression, and an increase in endothelin-1 plasma levels, with all mice dying within 5 wk. Immunostaining and endothelial fate mapping showed a robust increase in TGFβ signaling leading to widespread endothelial-to-mesenchymal transition (EndMT). Fibrosis affecting the cardiac conduction system was responsible for the universal lethality in these mice. Other findings included renal endotheliosis, loss of fenestrated endothelia in endocrine organs, and hemorrhages. An ensemble computational intelligence strategy, comprising deep learning and probabilistic programing of RNA-seq data, causally linked the loss of ERK1/2 in HUVECs in vitro to activation of TGFβ signaling, EndMT, suppression of eNOS, and induction of endothelin-1 expression. All in silico predictions were verified in vitro and in vivo. In summary, these data establish the key role played by ERK1/2 signaling in the maintenance of vascular normalcy.

Citing Articles

Key RNA-binding proteins in renal fibrosis: a comprehensive bioinformatics and machine learning framework for diagnostic and therapeutic insights.

Chen J, Zhang B, Huang Q, Fang R, Ren Z, Liu D Ren Fail. 2025; 47(1):2463560.

PMID: 39957043 PMC: 11834823. DOI: 10.1080/0886022X.2025.2463560.


Succinate Regulates Endothelial Mitochondrial Function and Barrier Integrity.

Atallah R, Gindlhuber J, Platzer W, Rajesh R, Heinemann A Antioxidants (Basel). 2025; 13(12.

PMID: 39765906 PMC: 11673088. DOI: 10.3390/antiox13121579.


MEK inhibitors: a promising targeted therapy for cardiovascular disease.

Mohammed K, Madeddu P, Avolio E Front Cardiovasc Med. 2024; 11:1404253.

PMID: 39011492 PMC: 11247000. DOI: 10.3389/fcvm.2024.1404253.


Exploring unconventional targets in myofibroblast transdifferentiation outside classical TGF- signaling in renal fibrosis.

Lathan R Front Physiol. 2024; 15:1296504.

PMID: 38808357 PMC: 11130449. DOI: 10.3389/fphys.2024.1296504.


Midkine promotes renal fibrosis by stabilizing C/EBPβ to facilitate endothelial-mesenchymal transition.

Xu C, Chen J, Liang L, Chen S, Niu X, Sang R Commun Biol. 2024; 7(1):544.

PMID: 38714800 PMC: 11076470. DOI: 10.1038/s42003-024-06154-0.


References
1.
Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F . Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science. 1999; 286(5443):1374-7. DOI: 10.1126/science.286.5443.1374. View

2.
Laumonnier Y, Nadaud S, Agrapart M, Soubrier F . Characterization of an upstream enhancer region in the promoter of the human endothelial nitric-oxide synthase gene. J Biol Chem. 2000; 275(52):40732-41. DOI: 10.1074/jbc.M004696200. View

3.
Kasahara Y, Tuder R, Taraseviciene-Stewart L, Le Cras T, Abman S, Hirth P . Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest. 2000; 106(11):1311-9. PMC: 387249. DOI: 10.1172/JCI10259. View

4.
Selcher J, Nekrasova T, Paylor R, Landreth G, Sweatt J . Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn Mem. 2001; 8(1):11-9. PMC: 311358. DOI: 10.1101/lm.37001. View

5.
Shaarawy M, El Meleigy M, Rasheed K . Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome. J Soc Gynecol Investig. 2001; 8(1):27-31. View